Drug intelligence / Profile preview

trenbolone acetate

Development stage: Unknown
Lead developer: Sinovo
Modality: Small Molecules
Administration: Intramuscular

Overview

ACE-TREND is a brand name for trenbolone acetate, a potent synthetic anabolic androgenic steroid (AAS) produced by Sinovo. As a derivative of nandrolone, it functions as a high-affinity agonist of the androgen receptor (AR), exhibiting significantly stronger anabolic and androgenic activity than testosterone. It promotes muscle hypertrophy, increases nitrogen retention, and enhances red blood cell production. While primarily utilized in veterinary medicine to improve feed efficiency and muscle growth in cattle (under brands like Finaplix), it is also known in the context of performance enhancement and muscle-wasting conditions.

Brand names: ACE-TREND
Other names: Trenbolone Acetate

Targets

PR (Progesterone receptor)GR (Glucocorticoid receptor)AR (Adrenergic receptors)

Beyond the preview

Go deeper on trenbolone acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on trenbolone acetate.

Explore the full profile